Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $0.11 B | -30.58% |
2023 | $0.16 B | -34.28% |
2022 | $0.25 B | -75.21% |
2021 | $1.01 B | 472.91% |
2020 | $0.17 B | -9% |
2019 | $0.19 B | -75.64% |
2018 | $0.80 B | 78.18% |
2017 | $0.44 B | -13.09% |
2016 | $0.51 B | 54.29% |
2015 | $0.33 B | -11.35% |
2014 | $0.37 B | 418.7% |
2013 | $72.84 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Johnson & Johnson JNJ | $28.5 M | $0.59 B | ๐บ๐ธ USA |
Novartis NVS | $20.77 M | $81.53 M | ๐จ๐ญ Switzerland |
Pfizer PFE | $13.91 M | $0.31 B | ๐บ๐ธ USA |
Abbott Laboratories ABT | $14.63 M | $0.13 B | ๐บ๐ธ USA |
Eli Lilly LLY | $54.05 M | $0.11 B | ๐บ๐ธ USA |
Sanofi SNY | $29.8 M | $76.77 M | ๐ซ๐ท France |
Biogen BIIB | $22.83 M | $75.97 M | ๐บ๐ธ USA |
Merck MRK | $5.8 M | $0.14 B | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $0.23 B | $0.33 B | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $17.9 M | $24.11 M | ๐ฌ๐ง UK |